Jan 14, 2021 / 03:00PM GMT
Tessa Thomas Romero - JPMorgan Chase & Co, Research Division - Associate
Welcome everyone to the 39th Annual JPMorgan Virtual Health Care Conference. My name is Tess Romero. I'm one of the biotech analysts here at JPMorgan, and the next presenting company that I'm pleased to present is Rigel, and speaking on behalf of the company is CEO, Raul Rodriguez.
And before I turn it over to Raul, I just want to remind everyone that for those on the webcast, if you do have a question, please use the "ask a question" feature in the portal and I would be happy to ask the question on your behalf. Raul, over to you.
Raul R. Rodriguez - Rigel Pharmaceuticals, Inc. - President, CEO & Director
Thank you, Tessa, and thank you again to our colleagues at JPMorgan for inviting us to present at their conference. An unusual year, for sure, but it's been a very good year for us, in terms of this conference, and very much appreciate that.
So let me tell you a little bit about Rigel, what we've accomplished, what we look to accomplish in the coming year and
Rigel Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 14, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers